Kinesiophobia, Pain, Balance, Quality of Life and Mental Status in Hemodialysis Patients

Investigation of the Relationship Between Kinesiophobia and Pain, Balance, Quality of Life and Mental Status in Hemodialysis Patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06696274

Enrollment

Registered

2024-11-20

Start date

2024-11-18

Completion date

2026-01-31

Last updated

2024-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease (ESRD), Hemodialysis

Brief summary

The aim of our study was to investigate the relationship between kinesiophobia and pain, balance, physical performance, quality of life and mental status in patients receiving hemodialysis.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with end stage renal disease receiving hemodialysis * Receiving hemodialysis for more than 3 months * Being clinically stable * Volunteering to participate in this stud

Exclusion criteria

-Having musculoskeletal disorders that may affect physical performance

Design outcomes

Primary

Measure	Time frame	Description
Kinesiophobia	Day 1	It will be evaluated with the Tampa Kinesiophobia scale.The total score ranges from 17-68, with a score above 37 indicating a high degree of kinesiophobia.
Pain	Day 1	Will be evaluated with a numeric rating scale. Higher scores indicate worse outcomes.
Balance	Day 1	It will be assessed with a timed up and go test
Physical performance	Day 1	It will be evaluated with five-repetition sit-to-stand test

Secondary

Measure	Time frame	Description
Mental health	Day 1	It will be assessed using the Hospital Anxiety and Depression scale. The lowest score they can get from both subscales is 0 and the highest score is 21.High scores indicate high levels of anxiety and depression
Comorbidity level	Day 1	It will be evaluated with the Charlson Comorbidity Index. Total score is between 0-37. Higher scores indicate worse outcomes and higher risk of death.
Quality of life	Day 1	It will be evaluated with the Short Form-36 Quality of Life scale.The subscales rate health from 0 to 100, with 0 indicating poor health and 100 indicating good health.

Countries

Turkey (Türkiye)

Contacts

Primary ContactMerve Firat

mervefirat@ahievran.edu.tr+90 850 441 02 44

Outcome results